000120958 001__ 120958
000120958 005__ 20240319081013.0
000120958 0247_ $$2doi$$a10.3389/fpsyg.2022.861643
000120958 0248_ $$2sideral$$a131273
000120958 037__ $$aART-2022-131273
000120958 041__ $$aeng
000120958 100__ $$aLear-Claveras, Ana
000120958 245__ $$aAnalysis of Drug and Health Resource Use Before and After COVID-19 Lockdown in a Population Undergoing Treatment for Depression or Anxiety
000120958 260__ $$c2022
000120958 5060_ $$aAccess copy available to the general public$$fUnrestricted
000120958 5203_ $$aIntroductionThe arrival of the COVID-19 pandemic modified the functions of Primary Care (PC) teams, which were forced to focus their resources on the diagnosis and treatment of SARS-CoV-2 infected patients. The disrupted healthcare of individuals with pre-existing mental disorders (depression or anxiety), as well as the psychological decompensation resulting from the lockdown caused by the COVID-19 pandemic, may have modified the use of drugs and health resources by these patients. The aim of this study is to determine the changes in these parameters, between the 6 months prior to the lockdown (09/14/2019 to 03/15/2020) and the 6 months following its end (05/03/2020 to 11/04/2020), in a population undergoing active treatment for depression or anxiety, according to the electronic clinical record.Materials and MethodsReal world data observational study of 110,694 individuals aged >16 years suffering from active or undergoing treatment for depression or anxiety according to the electronic medical records of the Aragon Regional Health Service (Spain). Pharmacological variables [daily dose per inhabitant (DHD) dispensed by pharmacies of: anxiolytics, hypnotics/sedatives, and antidepressants] and variables related to the use of healthcare resources (number of primary and specialized healthcare visits) were considered. Student’s T-tests for paired samples were performed to analyze differences between periods (pre–post). The level of significance was established at 5% (p < 0.05).ResultsThe use of anxiolytic drugs increased as compared to its use over the 6 months prior to the lockdown. In contrast, the consumption of antidepressants was found to decrease. The use of health resources continued to be below pre-pandemic levels, 6 months post-lockdown end.ConclusionChanges in the use of health resources could have a negative impact on the parameters of these diseases. The increase in drug use, especially benzodiazepines, may suggest a worsening of the symptoms during the lockdown and in the subsequent months. It is a worrying sign, which points to the growth of this public health problem and the need for its prevention.
000120958 536__ $$9info:eu-repo/grantAgreement/ES/DGA/B21-20R-GAIAP
000120958 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000120958 590__ $$a3.8$$b2022
000120958 592__ $$a0.891$$b2022
000120958 591__ $$aPSYCHOLOGY, MULTIDISCIPLINARY$$b34 / 147 = 0.231$$c2022$$dQ1$$eT1
000120958 593__ $$aPsychology (miscellaneous)$$c2022$$dQ2
000120958 594__ $$a4.5$$b2022
000120958 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000120958 700__ $$aClavería, Ana
000120958 700__ $$aCouso-Viana, Sabela
000120958 700__ $$aNabbe, Patrice
000120958 700__ $$0(orcid)0000-0001-6565-9699$$aOliván-Blázquez, Bárbara$$uUniversidad de Zaragoza
000120958 7102_ $$14009$$2740$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicología Social
000120958 773__ $$g13 (2022), 861643 [8 pp.]$$pFront. psychol.$$tFrontiers in Psychology$$x1664-1078
000120958 8564_ $$s262582$$uhttps://zaguan.unizar.es/record/120958/files/texto_completo.pdf$$yVersión publicada
000120958 8564_ $$s2295594$$uhttps://zaguan.unizar.es/record/120958/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000120958 909CO $$ooai:zaguan.unizar.es:120958$$particulos$$pdriver
000120958 951__ $$a2024-03-18-15:22:40
000120958 980__ $$aARTICLE